FDA Commissioner Scott Gottlieb, MD, announced he will step down from his position early next month, leaving a 2-year tenure as head of the agency.
HHS Secretary Alex Azar lauded Gottlieb’s leadership of the FDA, including his perseverance in curbing youth tobacco and e-cigarette use and his tenacity to move treatment and generic drug approvals through the process efficiently.
“The public health of our country is better off for the work Scott and the entire FDA team have done over the last 2 years,” Azar said in a press release.
(Read more...)

Full Story →

FDA Commissioner Scott Gottlieb, MD, announced he will step down from his position early next month, leaving a 2-year tenure as head of the agency.
HHS Secretary Alex Azar lauded Gottlieb’s leadership of the FDA, including his perseverance in curbing youth tobacco and e-cigarette use and his tenacity to move treatment and generic drug approvals through the process efficiently.
“The public health of our country is better off for the work Scott and the entire FDA team have done over the last 2 years,” Azar said in a press release.
(Read more...)

Full Story →